BioCentury
ARTICLE | Clinical News

Custom NX: Additional pilot trial data

October 29, 2007 7:00 AM UTC

Additional data from the pilot, European CUSTOM II trial showed that 6-month results were sustained at 1-year follow up. There were no new MACE events, the incidence of late stent thrombosis was 0%, a...